The Role of Hematological Inflammatory Biomarkers in the Diagnosis of Lung Cancer and in Predicting TNM Stage

GÖKSEL S., ÖZÇELİK N., Telatar G., ARDIÇ C.

CANCER INVESTIGATION, cilt.39, sa.6-7, ss.514-520, 2021 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 39 Sayı: 6-7
  • Basım Tarihi: 2021
  • Doi Numarası: 10.1080/07357907.2021.1938110
  • Dergi Adı: CANCER INVESTIGATION
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, BIOSIS, CAB Abstracts, CINAHL, EMBASE, MEDLINE, Veterinary Science Database
  • Sayfa Sayıları: ss.514-520
  • Anahtar Kelimeler: Diagnostic value, lung cancer, mean platelet volume, neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, NEUTROPHIL-TO-LYMPHOCYTE, PLATELET, RATIO
  • Recep Tayyip Erdoğan Üniversitesi Adresli: Evet

Özet

Objective The aim of study is to investigate whether hematological inflammatory biomarkers could be useful to detect patients with lung cancer. Methods The contribution of hematological biomarkers to the diagnosis of lung cancer and prediction of TNM was examined. Results NLR, PLR, MPV values were found to be higher in patients with lung cancer (all p < .001). NLR and PLR were found to be high, MPV was found to be lower in disease of advanced stage (p < .001). Conclusions This study found that NLR, PLR and MPV values were significantly higher in patients with lung cancer.